Pharmaceutical companies in China report importing drugs with tariff exemptions, indicating possible flexibility from Chinese ...

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among ...

Levels of mortgage approvals have been remarkably resilient in the first part of this year which seems surprising given the concerns about the health of the UK economy as we enter into Q2, and some ...

The dispensation is the latest sign that the world's two largest economies were prepared to rein in their trade war, ...

A global biopharma is fighting malaria in endemic countries through partnerships that harness R&D, broaden access to ...

Peter Gratton, M.A.P.P., Ph.D., is a New Orleans-based editor and professor with over 20 years of experience in investing, risk management, and public policy. Peter began covering markets at ...

Hanwha, which bought the South Philly yard last year, wants to add waterfront land and may expand into South Jersey.

Granite will focus on two antibody therapies, both targeting crucial players in the inflammatory cascade to address ...

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

The Vaccines for Children program is funded by the U.S. Centers for Disease Control and Prevention and administered by state ...

Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...

It seems like not a day goes by without billionaire Elon Musk making headlines. The boss of X (formerly Twitter), Tesla and SpaceX is the world's richest person and has used his platform to make ...